Description
A randomized controlled trial conducted in Dhaka Medical College Hospital and outpatient settings across Dhaka, Mymensingh, and Sylhet has provided important insights into the treatment of multi-drug resistant (MDR) typhoid fever. The study, carried out from January to December 2017, evaluated the efficacy of ciprofloxacin, azithromycin, and cefixime in treating uncomplicated typhoid caused by Salmonella enterica serovar Typhi. The findings suggested that a seven-day course of azithromycin may be an effective and well-tolerated option for uncomplicated typhoid fever caused by MDR S. Typhi, offering a potential new standard for treatment in regions with high resistance rates.